XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Additional Paid–In Capital
Accumulated Deficit
Total
Balance at Sep. 30, 2019 $ 13,494 $ 15,987,799 $ (17,238,871) $ (1,237,578)
Balance (in Shares) at Sep. 30, 2019 4,497,930      
Issuance of common stock under securities purchase agreement $ 142 254,858   255,000
Issuance of common stock under securities purchase agreement (in Shares) 47,223      
Issuance of warrants in connection with convertible notes offering   419,635   419,635
Stock-based compensation   463,084   463,084
Issuance of common stock for consulting services $ 90 124,503   124,593
Issuance of common stock for consulting services (in Shares) 30,002      
Issuance of common stock upon vesting of restricted stock units $ 11 (11)    
Issuance of common stock upon vesting of restricted stock units (in Shares) 3,501      
Net loss     (4,637,066) (4,637,066)
Balance at Dec. 31, 2019 $ 13,737 17,249,868 (21,875,937) (4,612,332)
Balance (in Shares) at Dec. 31, 2019 4,578,656      
Conversion of convertible notes into common stock $ 61 239,461   239,522
Conversion of convertible notes into common stock (in Shares) 20,283      
Exercise of stock options $ 42 1,446   1,488
Exercise of stock options (in Shares) 14,175      
Stock-based compensation   88,806   88,806
Issuance of common stock for consulting services $ 61 153,520   153,581
Issuance of common stock for consulting services (in Shares) 20,334      
Issuance of common stock upon vesting of restricted stock units $ 122 289,272   289,394
Issuance of common stock upon vesting of restricted stock units (in Shares) 40,727      
Net loss     (1,345,642) (1,345,642)
Balance at Mar. 31, 2020 $ 14,023 18,022,373 (23,221,579) (5,185,183)
Balance (in Shares) at Mar. 31, 2020 4,674,175      
Conversion of convertible notes into common stock $ 4,026 7,845,405   7,849,431
Conversion of convertible notes into common stock (in Shares) 1,341,927      
Issuance of broker warrants in connection with convertible notes offering   277,037   277,037
Issuance costs in connection with conversion of convertible notes into common stock   (161,881)   (161,881)
Exercise of stock options $ 34 1,157   1,191
Exercise of stock options (in Shares) 11,340      
Stock-based compensation   103,998   103,998
Issuance of common stock for consulting services $ 142 241,008   241,150
Issuance of common stock for consulting services (in Shares) 47,362      
Issuance of common stock upon vesting of restricted stock units $ 15 38,520   38,535
Issuance of common stock upon vesting of restricted stock units (in Shares) 5,128      
Net loss     (7,091,060) (7,091,060)
Balance at Jun. 30, 2020 $ 18,240 26,367,617 (30,312,639) (3,926,782)
Balance (in Shares) at Jun. 30, 2020 6,079,932      
Balance at Sep. 30, 2020 $ 22,181 32,923,022 (30,879,031) 2,066,172
Balance (in Shares) at Sep. 30, 2020 7,393,637      
Issuance of common stock upon conversion of convertible notes $ 878 1,004,354   1,005,232
Issuance of common stock upon conversion of convertible notes (in Shares) 292,754      
Issuance cost settlement in connection with private placement   50,400   50,400
Stock-based compensation   245,829   245,829
Issuance of common stock upon vesting of restricted stock units $ 31 (31)    
Issuance of common stock upon vesting of restricted stock units (in Shares) 10,450      
Net loss     (1,959,480) (1,959,480)
Balance at Dec. 31, 2020 $ 23,090 34,223,574 (32,838,511) 1,408,153
Balance (in Shares) at Dec. 31, 2020 7,696,841      
Exercise of stock options $ 2 4,996   4,998
Exercise of stock options (in Shares) 758      
Issuance of common stock in connection with private placement $ 12,500 8,816,736   8,829,236
Issuance of common stock in connection with private placement (in Shares) 4,166,682      
Issuance of warrants stock in connection with private placement   3,670,764   3,670,764
Issuance costs in connection with private placement   (1,198,080)   (1,198,080)
Stock-based compensation   326,359   326,359
Exercise of stock warrants $ 120 212,379   212,499
Exercise of stock warrants (in Shares) 39,905      
Issuance of common stock upon vesting of restricted stock units $ 18 (18)    
Issuance of common stock upon vesting of restricted stock units (in Shares) 6,131      
Net loss     (2,393,916) (2,393,916)
Balance at Mar. 31, 2021 $ 35,730 46,056,710 (35,232,427) 10,860,013
Balance (in Shares) at Mar. 31, 2021 11,910,317      
Exercise of stock options $ 1 5,147   5,148
Exercise of stock options (in Shares) 780      
Stock-based compensation $ 51 878,801   878,852
Stock-based compensation (in Shares) 51,328      
Exercise of stock warrants $ 11 62,490   62,501
Exercise of stock warrants (in Shares) 11,141      
Issuance of common stock upon vesting of restricted stock units $ 8 (8)    
Issuance of common stock upon vesting of restricted stock units (in Shares) 7,814      
Net loss     (2,951,609) (2,951,609)
Balance at Jun. 30, 2021 $ 35,801 $ 47,003,140 $ (38,184,036) $ 8,854,905
Balance (in Shares) at Jun. 30, 2021 11,981,380